|
|
| | Urea, N-[5-chloro-6-(2H-1,2,3-triazol-2-yl)-3-pyridinyl]-N'-[8-[(1S)-1-methoxyethyl]imidazo[1,2-b]pyridazin-7-yl]- Basic information |
| | Urea, N-[5-chloro-6-(2H-1,2,3-triazol-2-yl)-3-pyridinyl]-N'-[8-[(1S)-1-methoxyethyl]imidazo[1,2-b]pyridazin-7-yl]- Chemical Properties |
| density | 1.60±0.1 g/cm3(Predicted) | | pka | 6.22±0.46(Predicted) |
| | Urea, N-[5-chloro-6-(2H-1,2,3-triazol-2-yl)-3-pyridinyl]-N'-[8-[(1S)-1-methoxyethyl]imidazo[1,2-b]pyridazin-7-yl]- Usage And Synthesis |
| Uses | RGT-068A is a potent, selective and oral bioavailable MALT1 inhibitor[1]. | | References | [1] Feng S, et, al. Direct Construction of Chiral Ether via Highly Efficient Heck Reaction and N-Directed Asymmetric Hydrogenation for Large-Scale Synthesis of MALT1 Inhibitor RGT-068A. Org. Process Res. Dev. 2022. |
| | Urea, N-[5-chloro-6-(2H-1,2,3-triazol-2-yl)-3-pyridinyl]-N'-[8-[(1S)-1-methoxyethyl]imidazo[1,2-b]pyridazin-7-yl]- Preparation Products And Raw materials |
|